Raymond James Financial’s Greenwich LifeSciences GLSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-9,137
Closed -$214K – 5536
2026
Q2
$214K Sell
9,137
-700
-7% -$17K ﹤0.01% 5011
2026
Q1
$236K Buy
+9,837
New +$257K ﹤0.01% 4799
2025
Q3
– Sell
-718
Closed -$6.51K – 5667
2025
Q2
$6.51K Buy
+718
New +$6.83K ﹤0.01% 6081

Other funds holding GLSI

Raymond James Financial's GLSI Position: Q3 2026 in Review

Raymond James Financial sold out of Greenwich LifeSciences (GLSI) in Q3 2026, closing a stake of 9,137 shares — an estimated $214K sold.

Raymond James Financial first reported a position in GLSI in Q2 2025 and held it in 3 quarters. The position peaked at $236K in Q1 2026. 53 funds tracked by Wall St. Rank hold GLSI as of Q3 2026.

  • Raymond James Financial reported no remaining Greenwich LifeSciences position as of Q3 2026 after selling out during the quarter.
  • Raymond James Financial sold 9,137 Greenwich LifeSciences shares in Q3 2026, an estimated $214K.
  • Raymond James Financial first reported a position in Greenwich LifeSciences in Q2 2025 and held it in 3 quarters.
  • Raymond James Financial's Greenwich LifeSciences position peaked at $236K in Q1 2026.
  • 53 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q3 2026.

Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.